• About
    • About Us
    • Leadership
  • Investors
    • Overview
    • Press Releases
    • Governance
    • SEC Filings
    • Stock Info
    • Email Alerts
  • Contact

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

by B2i | Mar 27, 2026 | Press Releases

Gaithersburg, Maryland–(Newsfile Corp. – March 27, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced a major advancement to its molecule.ai platform,...

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

by B2i | Mar 26, 2026 | Press Releases

Gaithersburg, Maryland–(Newsfile Corp. – March 26, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced a major advancement to its molecule.ai platform,...

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

by B2i | Mar 6, 2026 | Press Releases

Gaithersburg, Maryland–(Newsfile Corp. – March 6, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), the owner of Molecule.ai, an artificial intelligence (“AI”)...

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs – and Why Molecule.ai’s Drug Discovery Platform Matters More Than Ever

by B2i | Jan 13, 2026 | Press Releases

Gaithersburg, Maryland–(Newsfile Corp. – January 13, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), applauds the state of Utah which has become the first state in the United...

Shuttle Pharmaceuticals Acquires AI Health Platform

by B2i | Nov 21, 2025 | Press Releases

Rockville, Maryland–(Newsfile Corp. – November 21, 2025) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle” or the “Company”) today announced that it has closed the acquisition of the assets and liabilities of...

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

by B2i | Nov 3, 2025 | Press Releases

Gaithersburg, Maryland–(Newsfile Corp. – November 3, 2025) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced that it entered into a securities purchase agreement with...
« Older Entries

Recent Posts

  • RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
  • Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
  • Shuttle Pharmaceuticals Announces $3.5 Million Public Offering
  • Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs – and Why Molecule.ai’s Drug Discovery Platform Matters More Than Ever
  • Shuttle Pharmaceuticals Acquires AI Health Platform

Recent Comments

No comments to show.

Contact

Shuttle Pharmaceuticals
401 Professional Drive
Suite 260
Gaithersburg, MD 20879

info@shuttlepharma.com

  • Follow
  • Follow
Sign up for Alerts

Site Links

  • Home
  • Investors
  • Privacy Policy
  • Contact

Our Company

  • About us
  • Leadership
© Copyright 2026 Shuttle Pharmaceuticals - All rights reserved
We use cookies to monitor and analyze how our site is used. By using our site, you agree to our use of cookies.